WINDLAS.NS · Windlas Biotech Limited
India · RS rating 62 · As of 2026-10-14
| Price | 917.30 INR |
|---|---|
| 1-day change | -1.9% |
| RS rating (overall / 1M / 3M / 12M) | 62 / 3 / 77 / 64 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 32 / 33 / 33 |
| Industry group (rank) | Pharma (32) |
| EPS growth Q/Q | +11.1% |
| Sales growth Q/Q | +4.0% |
| Distance from 52-week high | +20.6% |
| Market cap (USD) | $205.9M |